Pharma & Biotech

Compass Therapeutics is experiencing significant pre-market trading activity today following the release of encouraging preclinical results for its oncology candidate...

Biolife shares face a pivotal moment with the company scheduled to release its third-quarter 2025 financial results after market close...

The biotechnology sector is watching closely as BioNTech's proposed acquisition of CureVac enters its decisive phase. With a November 25...

Biotechnology firm Ocugen faces a pivotal moment this Wednesday, November 5, 2025, as it prepares to disclose its third-quarter financial...

Eli Lilly & Company appears poised to transform the competitive landscape of the multi-billion dollar weight-loss medication sector through a...

Market analysts are turning increasingly bullish on HealthEquity as the company benefits from favorable regulatory developments and strategic product launches....

Investors are closely monitoring Coherus BioSciences as the biotechnology firm prepares to release its third-quarter 2025 financial results after market...

Shares of Balchem Corporation demonstrated minimal movement in recent trading, holding steady despite the release of groundbreaking clinical data for...

The biotechnology sector is demonstrating its notoriously unforgiving nature, with ImmunityBio caught in a severe downturn. As the company's stock...

NuCana plc's stock continues to experience significant downward pressure, with shares declining 1.75% during the latest trading session to close...